These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1901332)

  • 21. Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils.
    Odell EW; Segal AW
    J Med Microbiol; 1991 Mar; 34(3):129-35. PubMed ID: 2010902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment.
    Naderi beni F; Fattahi F; Mirshafiey A; Ansari M; Mohsenzadegan M; Movahedi M; Pourpak Z; Moin M
    Int Immunopharmacol; 2012 Apr; 12(4):689-93. PubMed ID: 22330085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease.
    Goebel WS; Mark LA; Billings SD; Meyers JL; Pech N; Travers JB; Dinauer MC
    J Invest Dermatol; 2005 Oct; 125(4):705-10. PubMed ID: 16185269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease.
    Gallin JI; Zarember K
    Trans Am Clin Climatol Assoc; 2007; 118():175-85. PubMed ID: 18528501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy.
    Cruz CR; Lam S; Hanley PJ; Bear AS; Langston C; Cohen AJ; Liu H; Martinez CA; Krance RA; Heslop HE; Rooney CM; Hanson IC; Bollard CM
    Clin Exp Immunol; 2013 Oct; 174(1):89-96. PubMed ID: 23763437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro coagulation triggers anti-Aspergillus fumigatus neutrophil response.
    Fréalle E; Gosset P; Leroy S; Delattre C; Wacrenier A; Zenzmaier C; Zawadzki C; Aliouat EM; Perkhofer S
    Future Microbiol; 2018 May; 13():659-669. PubMed ID: 29790796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of NET formation by gene therapy in CGD controls aspergillosis.
    Bianchi M; Hakkim A; Brinkmann V; Siler U; Seger RA; Zychlinsky A; Reichenbach J
    Blood; 2009 Sep; 114(13):2619-22. PubMed ID: 19541821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human interferon-gamma in patients with chronic granulomatous disease--European follow up study.
    Weening RS; Leitz GJ; Seger RA
    Eur J Pediatr; 1995 Apr; 154(4):295-8. PubMed ID: 7607280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.
    Sechler JM; Malech HL; White CJ; Gallin JI
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4874-8. PubMed ID: 2838849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of therapy with recombinant human interferon-gamma on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease.
    Condino-neto A; Muscará MN; Bellinati-Pires R; Carneiro-Sampaio MM; Brandão AC; Grumach AS; De Nucci G
    J Interferon Cytokine Res; 1996 May; 16(5):357-64. PubMed ID: 8727075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease.
    International Chronic Granulomatous Disease Cooperative Study Group
    N Engl J Med; 1991 Feb; 324(8):509-16. PubMed ID: 1846940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease.
    Bernhisel-Broadbent J; Camargo EE; Jaffe HS; Lederman HM
    J Infect Dis; 1991 Apr; 163(4):908-11. PubMed ID: 1901336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical response to interferon-gamma in a patient with chronic granulomatous disease and brain abscesses due to Aspergillus fumigatus].
    Touza Rey F; Martínez Vázquez C; Alonso Alonso J; Méndez Piñeiro MJ; Rubianes González M; Crespo Casal M
    An Med Interna; 2000 Feb; 17(2):86-7. PubMed ID: 10829464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils.
    Ahlin A; Lärfars G; Elinder G; Palmblad J; Gyllenhammar H
    Clin Diagn Lab Immunol; 1999 May; 6(3):420-4. PubMed ID: 10225847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease, McLeod syndrome and hyper-IgE. Case report.
    Kantar A; Oggiano N; Gabbianelli R; Fabrizzi G; Giorgi PL
    Minerva Pediatr; 1994 Apr; 46(4):157-60. PubMed ID: 8084323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma in the management of chronic granulomatous disease.
    Gallin JI
    Rev Infect Dis; 1991; 13(5):973-8. PubMed ID: 1962114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections: A meta-analysis of the treatments.
    Loffredo L; Perri L; Zicari AM; Del Ben M; Angelico F; Violi F
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):285-9. PubMed ID: 27613462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD).
    Jackson SH; Miller GF; Segal BH; Mardiney M; Domachowske JB; Gallin JI; Holland SM
    J Interferon Cytokine Res; 2001 Aug; 21(8):567-73. PubMed ID: 11559434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.